Bausch Health Companies Inc is seeing a noticeable rise in its stock price, reflecting positive investor sentiment.
Bausch Health Companies Inc (BHC.TO) is up by 3.51% today, closing at CA$9.43. This increase follows the company's recent announcement about the winners of its 2026 Gastrointestinal Health Scholars Program, which underscores its commitment to supporting education in healthcare.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeAdvertisement
Market cap
$3.37B
52W high
$11.09
52W low
$6.10
1W change
+3.17%
Beta
0.38
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 23.1% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-23.1% Upside
Current Price
C$9.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
92.5%
Annualized
90-Day Vol
64.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.89
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.67 | C$7.03 – C$13.31 |
| 60 trading days | C$10.26 | C$6.53 – C$16.12 |
| 90 trading days | C$10.89 | C$6.26 – C$18.93 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may view Bausch Health's focus on community initiatives as a positive sign of its corporate responsibility and long-term vision.
Bausch Health's market cap reaches CA$3.37 billion
With a market cap of CA$3.37 billion, Bausch Health is a significant player in the pharmaceutical industry, but its negative profit margin of -10.12% raises concerns about its financial health.
Bull case
The recent scholarship program not only boosts Bausch Health's reputation but also strengthens brand loyalty among healthcare professionals and patients. This could lead to increased sales in its gastroenterology line.
Bear case
Despite the positive stock movement, Bausch Health faces challenges, including a lack of profitability and ongoing scrutiny of its business practices, which could affect its future performance.
Recent Developments
Advertisement
Bausch Health's stock performance today can be linked to its announcement about the winners of the 2026 Gastrointestinal Health Scholars Program. This initiative awards scholarships to students living with gastrointestinal diseases, highlighting the company's commitment to education and health.
Market Reaction
The stock's rise shows a positive market reaction, as investors often favor companies that engage in socially responsible initiatives. Bausch Health's efforts in education may enhance its corporate image and attract more investors looking for ethical investment opportunities.
Looking Ahead
While the current rise in stock price is encouraging, investors should remain cautious. Bausch Health continues to face challenges in profitability and public perception. Keeping an eye on future developments and financial performance will be crucial for assessing the sustainability of this upward trend.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
